More articles about Infectious Disease

The agreement will open markets in Denmark, Sweden, and Norway for SpeeDx's STI detection product lines.

The funding will be used to pay for clinical trials in the US that will be used as underlying evidence for FDA clearance of the test, the company said.

ExcitePCR's technology detects pathogens in 30 minutes or less using a backpack-sized device, integrating sample prep with PCR and RIF technology in a disposable cartridge.

Curetis and BGI subsidiary MGI Tech plan to develop NGS-based diagnostics for microbial infections on the MGISeq instrument for the Chinese market. 

GenomeDx will have exclusive rights to distribute the molecular tests in most of the US, while Pathnostics continues to perform the assays in-house.

The firms will use MGI's sequencing technology and Curetis' sample prep platform and antibiotic resistance database to develop IVDs, initially for China.

The British-based firm says that its assay detects hepatitis C via a single-use, disposable cartridge within 90 minutes of testing. 

A new genome sequence study suggests sequence conservation is more common in HPV16 isolates from individuals with cancer or pre-cancerous conditions.

Variants in and around inflammation-related gene CD53 were linked to TB in older Thai individuals infected with certain Mycobacterium tuberculosis lineages.

The two projects aim to use genomics to prevent the spread of drug-resistant bacteria and expand the use of genomic testing in cancer, respectively.

The firm reported an 88 percent increase in product sales, but this was offset by a 79 percent drop in collaboration revenues.

More than a dozen Yersinia pestis sub-populations turned up in a genome sequence and genotype analysis of strains collected across the country over 18 years.

Medcis Pathlabs and its associates and attendees will buy Co-Diagnostics' tests for hepatitis B, hepatitis C, HIV, and human papillomavirus.

The panel, developed by collaborator Janssen, is expected to improve detection of influenza and respiratory syncytial virus.

The company plans to launch a test for gram-negative bacteria next, and will work with developers and freelancers to develop additional assay content

Investigators used gene expression and immunological profiling to detect distinct immune responses in dengue virus-infected children with or without symptoms.

The company also said that net income for the first half of 2017 rose 18 percent year over year to €101 million from €85.7 million.

The study is the first to demonstrate the design features and operational characteristics of Cepheid's Xpert MTB/RIF Ultra assay.

Investigators retraced features contributing to Lyme disease spread by sequencing 146 Borrelia burgdorferi isolates collected in North America since the 1980s.

The assays should be easy to perform and capable of detecting HIV from a finger-stick blood or other sample shortly after infection or treatment interruption.

Pages

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.